Author:
Huang Lihua,He Liuliu,Luo Xiaoyan,Zhou Xiaoqing
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. 11. Chronic kidney Disease and Risk Management: standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S219–30.
2. de Boer IH, Khunti K, Sadusky T, Tuttle KR, Neumiller JJ, Rhee CM, et al. Diabetes management in chronic kidney disease: a Consensus Report by the American Diabetes Association (ADA) and kidney disease: improving global outcomes (KDIGO). Diabetes Care. 2022;45(12):3075–90.
3. KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2022;102(5s):S1–127.
4. DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, et al. Type 2 diabetes mellitus. Nat Reviews Disease Primers. 2015;1:15019.
5. Gonzalez-Covarrubias V, Sánchez-Ibarra H, Lozano-Gonzalez K, Villicaña S, Texis T, Rodríguez-Dorantes M, Transporters, et al. TBC1D4, and ARID5B variants to explain Glycated Hemoglobin variability in patients with type 2 diabetes. Pharmacology. 2021;106(11–12):588–96.